#BristolMyersSquibb has reported phase 3 results with a new type of drug for #idiopathicpulmonaryfibrosis that could open the door to regulatory filings.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#BristolMyersSquibb has reported phase 3 results with a new type of drug for #idiopathicpulmonaryfibrosis that could open the door to regulatory filings.
@gmj-georgia.bsky.socialNew hope for IPF patients: landmark trial shows a novel therapy can slow lung function decline in idiopathic pulmonary fibrosis. Published in NEJM July 202… #Antifibrotictherapy #Idiopathicpulmonaryfibrosis #IPFtreatment #Lungdisease #NEJM2026 #Antifibrotictherapy #Idiopathicpulmonaryfibrosis #…
@dhsc-answers.bsky.socialA question on #IdiopathicPulmonaryFibrosis #Drugs tabled by Martin Wrigley on 07-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-07/27814
@dhsc-answers.bsky.socialA question on #IdiopathicPulmonaryFibrosis tabled by Baroness Ritchie of Downpatrick on 04-09-2026 has been answered by Baroness Merron. https://questions-statements.parliament.uk/written-questions/detail/2026-09-04/HL3112
@dhsc-answers.bsky.socialA question on #IdiopathicPulmonaryFibrosis #HealthServices tabled by Jim Shannon on 01-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-01/26008
@oxfordbrc.bsky.social@ouhospitals.bsky.social @nihr.bsky.social #PulmonaryFibrosis #IPF #PPFmonth #idiopathicpulmonaryfibrosis #lunghealth
@pharmaphorum.bsky.socialAn #AI-powered #imaging tool developed by #Brainomix has been used to enrich data from a phase 2a trial of #EndeavorBioMedicines' hedgehog pathway inhibitor #taladegib, in development for #idiopathicpulmonaryfibrosis (IPF).
@dhsc-answers.bsky.socialA question on #IdiopathicPulmonaryFibrosis #HealthServices tabled by Gideon Amos on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/24601